<!doctype html>
<html lang="en">

<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <link
    crossorigin="anonymous"
    href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/css/bootstrap.min.css"
    integrity="sha512-GQGU0fMMi238uA+a/bdWJfpUGKUkBdgfFdgBm72SUQ6BeyWjoY/ton0tEjH+OSH9iP4Dfh+7HM0I9f5eR0L/4w=="
    referrerpolicy="no-referrer"
    rel="stylesheet"
  />
  <link rel="stylesheet" href="./static/css/oxford.css">
  <link rel="stylesheet" href="./static/css/outliers.css">

  <title>Static outliers for Balham, Tooting & Furzedown PCN</title>
</head>
<body>
    <div class="bg-dark">
      <div class="container d-flex justify-content-center">
        <a class="visually-hidden-focusable text-white p-2" href="#content">Skip to main content</a>
      </div>
    </div>

    <header>
      <nav class="navbar navbar-expand-lg navbar-dark bg-dark bg-oxford">
        <div class="container">
          <a class="navbar-brand" href="../index.html">OpenPrescribing outlier detection</a>
        </div>
      </nav>
    </header>

    <main id="content">
      <div class="bg-oxford-50 mb-4">
        <div class="container pt-5 pb-4">
          <div class="row">
            <div class="col-12">
              <h1 class="display-5 fw-bold lh-1">Static outliers for Balham, Tooting & Furzedown PCN</h1>
            </div>
            <div class="col-lg-8 col-md-9 col-12 pt-4 fs-5">
              <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
                explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
                prescribers and organisations to audit and review prescribing.</p>
              <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
                  in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the
                  mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
                  population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
              </p>
              <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
                  it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
              </p>
              <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=pcn+U42598">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
                  send short or detailed feedback.
              </p>
            </div>
          </div>
        </div>
      </div>
    </main>

    <section aria-labelledby="higherHeading">
      <div class="container">
        <h2 class="pb-3" id="higherHeading">Prescribing where Balham, Tooting & Furzedown PCN is higher than most</h2>
      </div>
      <div class="container px-lg-4 mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr class="row_1">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0309020I0&amp;denomIds=3.9.2&amp;selectedTab=summary">Squill</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>7</td>
      <td>Expectorant and demulcent cough preparations</td>
      <td>27</td>
      <td>0.26</td>
      <td>0.0</td>
      <td>0.01</td>
      <td>24.54</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_vMEcgxdcUDgXXhgjicYKfsQvSKgJbmMU"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_vMEcgxdcUDgXXhgjicYKfsQvSKgJbmMU" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0309020I0BBAAA0&amp;denomIds=3.9.2&amp;selectedTab=summary" target="_blank">Covonia mentholated cough mixture : 7</a></li></ul></td></tr><tr class="low_number row_2">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0403040R0&amp;denomIds=4.3.4&amp;selectedTab=summary">Oxitriptan</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>3</td>
      <td>Other antidepressant drugs</td>
      <td>4859</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>22.96</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_xMh6eQEisGoMvFBjIghCYkRForhI1ASv"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_xMh6eQEisGoMvFBjIghCYkRForhI1ASv" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0403040R0BEAAAK&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">HealthAid 5-HTP HydroxyTryptoPhan 50mg tablets : 3</a></li></ul></td></tr><tr class="low_number row_3">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0309020R0&amp;denomIds=3.9.2&amp;selectedTab=summary">Dextromethorphan hydrobrom compound prepartions</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Expectorant and demulcent cough preparations</td>
      <td>27</td>
      <td>0.04</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>13.52</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_ZS9E0gZfFIVUgqkVRIkpYSNCYWFhD2y6"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_ZS9E0gZfFIVUgqkVRIkpYSNCYWFhD2y6" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0309020R0AAABAB&amp;denomIds=3.9.2&amp;selectedTab=summary" target="_blank">Diphenhydramine 10mg / Dextromethorphan 6.65mg/5ml soln SF : 1</a></li></ul></td></tr><tr class="row_4">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=1003020AD&amp;denomIds=10.3.2&amp;selectedTab=summary">Arnica montana</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>10</td>
      <td>Rubefacients, topical NSAIDS, capsaicin and poultice</td>
      <td>2535</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>13.17</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_DJGYxohO3GIEdKCSxSjKDpCEODikZZ"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_DJGYxohO3GIEdKCSxSjKDpCEODikZZ" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=1003020ADBBAAAA&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Atrogel Arnica gel : 10</a></li></ul></td></tr><tr class="low_number row_5">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=1305020T0&amp;denomIds=13.5.2&amp;selectedTab=summary">Tazarotene</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>2</td>
      <td>Preparations for psoriasis</td>
      <td>371</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>7.72</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_baJvIE2IBuTFC5oI8QZqNNhKQkRFwagb"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_baJvIE2IBuTFC5oI8QZqNNhKQkRFwagb" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=1305020T0AAABAB&amp;denomIds=13.5.2&amp;selectedTab=summary" target="_blank">Tazarotene 0.1% gel : 2</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <section aria-labelledby="lowerHeading">
      <div class="container">
        <h2 class="pb-3" id="lowerHeading">Prescribing where Balham, Tooting & Furzedown PCN is lower than most</h2>
      </div>
      <div class="container px-lg-4 mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr class="row_1">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0&amp;denomIds=9.6.4&amp;selectedTab=summary">Colecalciferol</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>13174</td>
      <td>Vitamin D</td>
      <td>14219</td>
      <td>0.93</td>
      <td>0.97</td>
      <td>0.01</td>
      <td>-2.74</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_ekoBSQKiCIgKLtFAoUeiR8KuKwKDjCKg"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_ekoBSQKiCIgKLtFAoUeiR8KuKwKDjCKg" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AAACAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,000unit tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AAANAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit capsules : 602</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AABFBF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 600unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AABGBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit tablets : 370</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AABHBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit capsules : 36</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AABIBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit capsules : 53</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AABSBS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g tablets : 79</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AABTBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000units/ml oral drops sugar free : 15</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AABUBU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 1.25g chew tab : 12</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AABWBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g chew tab : 355</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AABXBX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 440unit/Calcium carb 1.25g efferv gran sach : 46</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AABYBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g chewable tab : 2666</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AABZBZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit/Calcium phosphate 3.1g oral pdr sach : 20</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AACBCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g efferv tab : 238</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AACDCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 750mg tablets : 392</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AACICI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400units/dose oral spray sugar free : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AACRCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit tablets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AACSCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit tablets : 379</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AACVCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 40,000unit capsules : 20</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AACYCY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AADBDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000unit tablets : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AADHDH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000units/1ml soln ud amp sugar free : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AADKDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AADNDN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral drops sugar free : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AADQDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,400units/ml oral drops sugar free : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AADRDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit capsules : 21</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AAEEEE&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 4,000unit tablets : 27</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AAEKEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AAELEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit tablets : 72</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AAEQEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AAETET&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400units/ml oral drops sugar free : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0AAFGFG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200units/drop oral drops : 14</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BHAABN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">BabyD 1,000units/ml oral solution : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BIAABI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 400unit capsules : 29</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BIABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 1,000unit capsules : 18</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BIACDX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,500unit capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BIADDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 10,000unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BIAGBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml liquid drops : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BIAJAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 800unit capsules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BKAABS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 tablets : 176</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BKABDI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 One a Day 1000mg/880unit chewable tablets : 71</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BMAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Valupak Vitamin D3 1,000unit tablets : 73</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BMABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Valupak Vitamin D3 1,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BNAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 chewable tablets tutti frutti : 1943</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BNABBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Lemon chewable tablets : 315</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BNACCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Dissolve 1500mg/400unit effervescent tablets : 77</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BNADCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 750mg/200unit caplets : 1665</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BQAABW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calceos 500mg/400unit chewable tablets : 36</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BRAABU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 chewable tablets : 68</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BRABBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 Forte chewable tablets : 330</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BSAABZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calfovit D3 oral powder sachets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BUAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Natecal D3 600mg/400unit chewable tablets : 36</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BWABCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 10,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BWAIBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000units/ml oral drops : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BWAPDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 10,000unit capsules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BWAWDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 25,000unit tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BWBBDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 20,000unit capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BXAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 800unit capsules : 38</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BXABDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 3,200unit capsules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BXACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 20,000unit capsules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0BXADDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 2,740units/ml oral drops : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0CEADDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Bio-Vitamin D3 20,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0CGAADR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Hux D3 20,000unit capsules : 248</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0CHABBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 1,000unit tablets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0CJAACS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 800unit tablets : 1152</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0CJABEE&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 4,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0CNACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Plenachol D3 20,000unit capsules : 82</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0CNADCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Plenachol D3 40,000unit capsules : 51</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0CWAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Evacal D3 1500mg/400unit chewable tablets : 163</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0DFAADH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000units/1ml oral solution : 13</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0DFABDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 2,400units/ml oral drops : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0DFADAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 800unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0DHAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Stexerol-D3 1,000unit tablets : 843</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0DHABDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Stexerol-D3 25,000unit tablets : 46</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0DIAADN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Thorens 10,000units/ml oral drops : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0DIABDP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Thorens 25,000units/2.5ml oral solution : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0DMAAEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calci-D 1000mg/1,000unit chewable tablets : 175</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0906040G0DNAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Strivit-D3 800unit capsules : 3</a></li></ul></td></tr><tr class="row_2">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0603020T0&amp;denomIds=6.3.2&amp;selectedTab=summary">Prednisolone</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1298</td>
      <td>Use of corticosteroids</td>
      <td>1612</td>
      <td>0.81</td>
      <td>0.88</td>
      <td>0.03</td>
      <td>-2.39</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_xfQgxSqPCYwCCoqwgqGUhRUwIQkCQso"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_xfQgxSqPCYwCCoqwgqGUhRUwIQkCQso" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0603020T0AAAAAA&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 1mg tablets : 148</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0603020T0AAABAB&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 2.5mg tablets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0603020T0AAACAC&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 5mg tablets : 851</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0603020T0AAAFAF&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 2.5mg gastro-resistant tablets : 108</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0603020T0AAAGAG&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 5mg gastro-resistant tablets : 139</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0603020T0AAARAR&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 25mg tablets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0603020T0AAATAT&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 1mg gastro-resistant tablets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0603020T0AAAXAX&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 20mg tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0603020T0AABHBH&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 5mg soluble tablets : 39</a></li></ul></td></tr><tr class="row_3">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0408010G0&amp;denomIds=4.8.1&amp;selectedTab=summary">Gabapentin</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>913</td>
      <td>Control of epilepsy</td>
      <td>9377</td>
      <td>0.10</td>
      <td>0.23</td>
      <td>0.06</td>
      <td>-2.26</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_1xW8suvqou6Kygq4rgKKGJJkCwIgqTR"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_1xW8suvqou6Kygq4rgKKGJJkCwIgqTR" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0408010G0AAAAAA&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 100mg capsules : 282</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0408010G0AAABAB&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 300mg capsules : 448</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0408010G0AAACAC&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 400mg capsules : 52</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0408010G0AAAJAJ&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 600mg tablets : 124</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0408010G0AABGBG&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 50mg/ml oral solution sugar free : 7</a></li></ul></td></tr><tr class="row_4">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0202030S0&amp;denomIds=2.2.3&amp;selectedTab=summary">Spironolactone</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1066</td>
      <td>Potassium-sparing diuretics and aldosterone antagonists</td>
      <td>2082</td>
      <td>0.51</td>
      <td>0.72</td>
      <td>0.10</td>
      <td>-2.19</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_URgdy1FEcUMFZQsGAjKIZUBBcSMjGAxL"><img width="250" class="h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAVq0lEQVR4nO3deZgdVZ3G8e8JSUgMe5DIEigQkDXsMKAEhQESS8MgmxAWB8FRmEfc0JpRURgdy1FEcUMFZQsGAjKIZUBBcSMjGAxLAAeQgmAiwQSzkARIUvPH7zR909NJTjp9b917+v08Tz23b1V1P7+u5/bt9546i6uqChEREZG1GVR3ASIiItIZFBpEREQkiEKDiIiIBFFoEBERkSAKDSIiIhJEoUFERESCKDSIiIhIEIUGERERCaLQICIiIkEUGkRERCSIQoOIiIgEUWgQERGRIAoNIiIiEkShQURERIIoNIiIiEgQhQYREREJotAgIiIiQRQaREREJIhCg4iIiARRaBAREZEgCg0iIiISRKFBREREgig0xMK5EThX+W1E3eWIiEh8FBpEREQkyOC6CxARabYkK4YCWwFb9Ng2BYYDwxoeNwQc9qHK+Q3gFeBV/9i1LQYWNTwuBP4GvAC8UObpK83/7URax1VVVXcN0h/slsRi/2wjquqlOssRabUkKzYG9gLGAG8EdgC2949voPuffystAOYCs4Cyx/anMk/n1lCTSJ8pNMRCoUEGkCQrNgQOBo4A9gf2AXZazekrgOeA2cA8YH7DtgBY6rdl/vEVYCVQNWwAQ4ChfhuCtUqMADZu2DYBtgRej7VsbAVstIZfZS7wSMP2APBQmaevBl4KkZZSaIiFQoNELMmKDYBDgKOAtwKHYf+0Gz0NPAg8BPwJeAZ4Fphd5umKlhXbQ5IVrwNGA0nDthOwG7A7FkAaLQXuA6YB9wK/K/N0fmuqFVkzhYZYKDRIZJKsGIy1JJwAHI/dYuiyAPg1cA/we+DhMk8XtrrG9ZVkxRBgZ2Bvvx0EHIq1WHSpsBBxJ3AHcH+Zp8tbXKoIoNAQD4UGiUCSFQ74B+BsLCiM9IdWYgFhKvBLYEadrQfNlGTFIGAPrDXlMKx1ZbuGU/6OBYgpwNQyT5e0vEgZsBQaYqHQIB0syYrNgTOAc7HOjADLgbuAW4Dbyjx9oabyauWD1O7AOL+NxUZ4ACwBfgLchAKEtIBCQywUGqQDJVlxAHABcBLdfRSmA98Dbirz9MW6amtXvo/EOOyavRPrjAn2938j8H1gWpmnenOXfqfQEAuFBukQ/pPzOOBC4G1+9yJgEvC9Mk8fqKu2TpNkxXBgPHAyMAGbawLgcSw8XFfm6V9rKk8ipNAQC4UGaXO+09+pWFjougXxFPAV4NoyTxev7ntl7ZKs2BQ4BXgvNhwV7BbPFODyMk//p67aJB4KDbFQaJA25cPCmcCnsOGGYCMevgT8d6wdGuuUZMVeWGfSs7CZL8FGYHwNuFkzVUpfKTTEQqFB2sxqwsJU4AvAb3XPvfl8/4eJWL+RPf3uOcBlwBVlni6qqzbpTAoNsVBokDbh51c4A7iI7rDwU+DiMk/vq6uugcz3IzkS+CDWedIBL2ItD1/X5FESSqEhFgoNUjM/v8AJwH8Ab/K7FRbaTJIVuwMZ1gKxAfa+8S3gywN1WKuEU2iIhUKD1KRhNMTngf387l8An1Tnu/aVZMWOWKfUs7F5HxZjnVK/Uubpgjprk/al0BALhQapQZIVbwH+Ezjc77oP+PcyT++urypZF0lWbI21PLwfW4xrPtbv5Jtlni6tszZpPwoNsVBokBZKsmI/rGVhvN81E/gk8GN1cOxMSVbsAHwGG3ExCFsV9NPA1WWerqyzNmkfCg2xUGiQFkiy4k3AJdhkQmArS14E/FBDJ+Pg+zxcApzodz0AXFDm6W/rq0rahUJDLBQapImSrNgV+9R5GvYpdA7W4fEqjfmPU5IVhwBfxRYQA1vf4uNlnj5TX1VSN4WGWCg0SBMkWbELFhYmYmHhb8B/Yfe7tThS5PyImFOBLwLbAsuAHPhimafL6qxN6qHQEAuFBulHSVbsjE3KdDo2LG8eNoPjNzXd88CTZMUI4ON+GwY8Aby/zNNf1FqYtJxCQywUGqQfJFnxRiwsnIGFhflYWPiGwoL4YZrfpLsD7PXAR8s8nVtfVdJKCg2xUGiQ9ZBkxU7Y6Iez6A4Ll2KzBWqqYXmNn5fjRGw2ya2Bv2PzPVylkTPxU2iIhUKD9EGSFftiTc4nY2HhRbrDwsI6a5P25lfV/BxwPjYt9c+Ac8s8fbbWwqSpFBpiodAggfwnxbcBnwCO8bvnYZ8cL9dsgLIu/CiLHwC7A4uAjwJXqtUhTgoNsVBokLVIsmIocBLwIeBAv7vEWha+r9EQ0ldJVgwDPovdphgE/Bw4R60O8VFoiIVCg6xGkhWvB/4FOA+7Bw3wIDaMbkqZp8vrqk3ikmTFwcDVWKvDQuzWxSS1OsRDoSEWCg3SQ5IVB2JB4TRsQaIKuB2bsOcevZFLM/hWh4uxVgcHTAbOK/P0xVoLk36h0BALhQYBkqzYCJuM5/3A/n73IuAqbNjkU3XVJgNLkhVHANcBo4FZwJllnt5Ta1Gy3hQaYqHQMGD5jo37Y0scnwFs7A89DFwBXK+REFKHJCs2A76FBdkKm/PjU2WevlprYdJnCg2xUGgYcHxfhYnAPwNj/O6XgRuB7wDTdAtC2kGSFacB3wY2AX4PvLvM07LWoqRPFBpiodAwIPj7xeOxFoV3AEP8oQexYW/Xl3k6r6byRFYryYoE699wCDYh1Nllnt5aa1GyzhQaYqHQEK0kKwZj8yqcCpyAfVoDm7VxEvCDMk//WFN5IsGSrBgCfB7rJAnwdeDCMk9frq8qWRcKDbFQaIiK76dwCDby4WRglD/0MvAT4IfAT/RmK50oyYq3A9cCI4EHgFPKPH2y3qokhEJDLBQaopBkxZ5YUDgV2NHvXgHchQWFW9WpUWKQZMV2wA3A4dgIn/eVeTq53qpkbRQaYqHQ0JF8i8Le2AJAJwB7NBy+FwsKU8o8fb6G8kSayt96uwhbWdUB3wU+VObp0loLk9VSaIiFQkPH8EHhQCwknADs3HD4YSwoTC7z9OkayhNpuSQrjsL654wCHgFOLvP0sXqrkt4oNMRCoaGtJVkxCDgUa1F4F7B9w+E/ALcAt5R5+kQN5YnULsmKUcD1wD8CS4APlHl6bb1VSU8KDbFQaGg7vul1LNaacDzd6z6A3Xq4BfiRxquLGB+u/w24BFv46mrgX8s81ftZm1BoiIVCQ1vwK0keibUoHAds6Q+tBH6FBYVbyzydXU+FIu0vyYqx2G26bYBHgZPKPH203qoEFBriodBQmyQrNgSOxpadPg7Y1B9ajo16uAW4rczTF+qpUKTz+BlPrwOOxW5XnF/m6dW1FiUKDdFQaGgpPzPjsViLwgS6J1x6GbgTCwq3a2U/kb7ztys+AXwOu11xDRYe9P5WE4WGWCg0NF2SFcOBcViLwjuBjfyhZcBU4GZswiXNoyDSj5KsOBy7XbEt8Bh2u2JmvVUNTAoNsVBoaIokK14HvB1rUXgHMMIfWgr8FJgC/LTM00X1VCgyMPjbFddiwX0pcD5wtRZlay2FhlgoNPSbJCtGACnWovB24HX+0BKgoDso6BqLtJC/XXEhtn7FBlifh/PKPF28xm+UfqPQEAuFhvXiRz2Mw6ZwngAM94deAm7Hbj1MLfN0ST0VikiXJCvegq2YuS3wBLbU9gP1VjUwKDTEQqFhnflPLYdjQeEkYHN/aDHwY6xF4U5NaSvSfpKs2BL4Pta/6FVsfofLyjxdWWthkVNoiIVCQxA/hfM+wETg3cB2/tCrWB+FG7DOjGpREGlz/u/5POBSYEPgZ8BZZZ7+tdbCIqbQEAuFhjVKsiIBTsdaFXb3uyvgHiwo3KLhkSKdKcmKvbHRFXsCLwDvLfP09nqripNCQywUGv6fJCs2xqZwfg9wRMOhB7DFcW4s8/QvNZQmIv3MD4n+MtbyAHAV8GGNbOpfCg2xUGgAXuun8DbgLCwwdI18eBYbrjWpzNPHaypPRJosyYoUCwyjgBI4s8zT39RaVEQUGmIxwENDkhW7Amf6bbTf/RI26uEa4FfqICUyMPhOkldgHxwqrAXiojJPl9VaWAQUGmIxAENDkhWbAadgrQqHNhz6JbY63o80fltkYPKdJCcC38DWg3kM6+swrdbCOpxCQywGSGjwy00fjfVTOA7rMQ3wJNaicF2Zp8/UU52ItJskK0ZjtyuOxlodLgc+qcnZ+kahIRYRhwb/iWFf7FPDROAN/tBC4EasVWGappMVkd7495D3AF8BNgOeBs4t8/TuOuvqRAoNsYgwNCRZsSM2RHIi3cMkV2Jjsa/BlpvWxEsiEiTJiq2BbwH/5HddDXxcy9aHU2iIRSShwXdgOgkLCm9uONQ1THJymaez66hNRDqfb3U4EevrsBXwIjab5JVlnq6os7ZOoNAQiw4ODX4lyQlYUBgHDPaHnsaCwg1lnj5WU3kiEiHfkfpz2LwODrgf+ECZp9NrLazNKTTEosNCg/+DTYF3YUGhaz6FeVg/hUmon4KINFmSFQdgtywOxjpKfhcbnjm31sLalEJDLDogNPg+CuOw+4lH0t2i0LWS5PXAz8o8fbWeCkVkIPKTwp0D5NjCdYuALwBfVb+pVSk0xKINQ4O/7fBW4FgsLOzacPhv2EqStwJ3adIVEalbkhUjgU8D52Mfap7F+jtM1uRwRqEhFm0QGpKs2AQ4DBjrt4OAoQ2nPAzcARTA78o8Xd7qGkVE1ibJil2ALwLH+13TgYuAqQP9lqlCQyxaHBqSrBgC7AUcAByIBYR9gUENp80H7saCwp1aHEpEOkmSFWOxZbcP9Lt+j4WHnw/U8KDQEIsmhQY/PGlbbMnZrm1vYAzdszF2eQ74NfAbvz2mJj0R6WT+PXACcDGwj9/9O+CzwN0DLTwoNMRiPUKDbzXYHtipYdvRP+4CbNLLt80H/tCwTQdmDbQ/IBEZGHxnyeOxsLCX3z0DWwzrpoHSgVuhIRarCQ0+JW+OtRZs4x+3ZdWQsD2r3lZotARb6GVmw/YI8KwCgogMND48nAh8Atjf734O+Co2QdSCumprBYWGDpZkxYZYENhmmwVzd7r3irOvBRhzweQpC4dtNIrugDBsLT/qL8CfV7M9r3AgIrIq/4HsCOBj2JwzYB/cbgC+B0yP8b1ToaHNJFkxDBjVsG21hucju75v+CvLeOyyEwHY/cM3s3ToazlhPhYKGrfZwCwsFJQa7igi0ndJVuwBfASb1bbrzXcGNlHUDTG1Pig0tECSFSOArVn1n//qAkFv/Qd6swyYgw8Cmy1d+PyMy0/7IMBR53z7mKdGjn4KmK1AICLSGn6m24nA+7DO4gBLsWHmNwFFmadLaiqvXyg0rIeGMLBNw2NvX4cGgYXAXOD5HlvPfXOBRas0fbXBPA0iIvLarYuDgHOBU4CN/aGu2W9vwoZtLu79J7QvhYZe+JkM1xQCur4OCQMLsRaBOcBf6T0APA/MXa/pShUaRETajr/lPB44GRu62bXOzivY0PQ7gKnAo53QB2JAhYYkK4YTFgY2Dfhxi7AgMLthm9Pj6zktS5IKDSIibc1/IO1aqO8YYIuGw7OweW5+i80DMbMd57mJIjT4JNf4T391gWCzgB/3EtZPoGcA6BkGFvXvb7GeFBpERDpGkhUbYDNNjsfW5jkYW6K7ywJgGjYPzoN+e6ruINGWocHfDxoBbMmqHQXfsJrnIbcJlrDmMDCbdgwDoRQaREQ6lu9EeSjwFuDNWIgY3uO0l4CHsLlznmjYnmxVB8umhoYkK0ZhHUB6bptizTIj/WPPr7dg1YWO1mQR1iegtxaBxq8XdcL9oj5TaBARiUaSFUOxaav3bXgcQ3enyp6ex25xzMJm572gGXU1OzT05YcvB+Zh8wvMxzoPNnYcXOV5pw9f6TcKDSIiUfOzUSbArtgU/12PuwCjgSFd55Z56nr5EettcDN+aIP7sZaAnttCVg0GjV8vjrpFQEREpA98f4au2XrvaDzmA8UoLDyMblYNbdmnQfpALQ0iItJkCg1tzjk3E6Cqqj3rriV2utato2vdOrrWrTMQrvXqVjYUERERWYVCg4iIiARRaBAREZEgCg0iIiISRKFBREREgig0iIiISBANuRQREZEgamkQERGRIAoNIiIiEkShQURERIIoNIiIiEgQhQYREREJotAgIiIiQRQa2ohz7q3OuZnOuSedc1c65zbo5ZzKOTejYRtZR62dLPA6j3LO3eace9w59yfn3DvqqLXTre1aO+f27fF6nu+cu6yuejtZ4Ov6Y/6ch5xzdzjnRtVRa6cLvNYX+3NmOuc+U0edzaDQ0Cacc4OAK4GTqqraGdgEOL2XU1dUVbVvwzavpYV2uHW4ztcAk6qq2g3YE5jWuirjEHKtq6qa0fh6BuYBU1pfbWcLudbOuV2ADwAHVlU1BpgBfKzVtXa6wGs9Hjga2B8YA+zjnBvb6lqbQaGhfRwEzK6q6lH//CrghBrridVar7Nz7k3AqKqqbgKoqmq5wlmfrNNr2jl3CDbh3L2tKC4yIdfaAUOA4c45h/2zm9O6EqMRcq33An5ZVdXLVVWtAO4CTmlhjU2j0NA+tgNmNTx/Fhjdy3mDnHP3O+emO+c+0prSohJynXcD5jrnfuic+6Nz7lrn3BYtqzAeoa/pLqcD1ze1onit9VpXVfW/wNf9eXOwFrSvtarAiIS8rv8IjHfObeqcGwYc18s5HUmhoX24wPN2qKrqIOAY4Hjn3KlNrClGIdd5MDAW+HxVVfsBJfClZhYVqdDXNM65wcDJKDT01Vqvte//9C5gZ2Bb4M/AhU2uK0ZrvdZVVd0FTALuAX4OPAysaG5ZraHQ0D5msWoS3R54rudJVVXN8o/zsBflYS2pLh4h13kW8GhVVY/455OBA1pQW2yCXtPescCfq6p6sulVxSnkWh+JXeM5vsl8Cnr/6IvQ9+pLq6rar6qqw4G/AI+3qL6mUmhoH38AtnPO7eGfvxf4UeMJzrnNfVMX/nEC8FBLq+x8a73O/pyhzrmuN4ajgZktqi8mIde6y+nAdS2pKk4h1/oZ4BDn3Cb++dHAo8i6CnmvHuSce73/emvgfcB3Wlplkyg0tAmf/M8BbnbOPQUsBq5zzk1wzl3pT9sNuN859yAwHWvyuqqWgjtUyHWuqmolcB5wm3PuIWAc6mW+zgJf0zjnNgLGAzfWU2nnC3xd34eNCrrPOfcwsAOQ11Vzpwp8XW8A/Mo5NxO4E7iwqqqyloL7mZbGFhERkSBqaRAREZEgCg0iIiISRKFBREREgig0iIiISBCFBhEREQmi0CAiIiJBFBpEREQkiEKDiIiIBFFoEBERkSAKDSIiIhJEoUFERESCKDSIiIhIEIUGERERCaLQICIiIkEUGkRERCSIQoOIiIgEUWgQERGRIAoNIiIiEkShQURERIIoNIiIiEgQhQYREREJotAgIiIiQRQaREREJIhCg4iIiAT5PyLRNOHNGfgbAAAAAElFTkSuQmCC"></button><div class="modal fade" id="plot_URgdy1FEcUMFZQsGAjKIZUBBcSMjGAxL" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0202030S0AAATAT&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 25mg tablets : 834</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0202030S0AAAUAU&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 50mg tablets : 118</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0202030S0AAAVAV&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 100mg tablets : 80</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0202030S0AACMCM&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 5mg/5ml oral solution : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0202030S0AAEGEG&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 12.5mg tablets : 30</a></li></ul></td></tr><tr class="row_5">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0502050C0&amp;denomIds=5.2.5&amp;selectedTab=summary">Terbinafine hydrochloride</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>106</td>
      <td>Other antifungals</td>
      <td>111</td>
      <td>0.95</td>
      <td>0.99</td>
      <td>0.02</td>
      <td>-2.17</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_NOlKJVAmMRmNJJpIBAuJgGgJBKJFE1wu"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_NOlKJVAmMRmNJJpIBAuJgGgJBKJFE1wu" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U42598&amp;numIds=0502050C0AAAAAA&amp;denomIds=5.2.5&amp;selectedTab=summary" target="_blank">Terbinafine 250mg tablets : 106</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <script
      crossorigin="anonymous"
      integrity="sha512-pax4MlgXjHEPfCwcJLQhigY7+N8rt6bVvWLFyUMuxShv170X53TRzGPmPkZmGBhk+jikR8WBM4yl7A9WMHHqvg=="
      referrerpolicy="no-referrer"
      src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/js/bootstrap.bundle.min.js"
    ></script>
    <script>
      var tooltipTriggerList = [].slice.call(
        document.querySelectorAll('[data-bs-toggle="tooltip"]')
      );
      var tooltipList = tooltipTriggerList.map(function (tooltipTriggerEl) {
        return new bootstrap.Tooltip(tooltipTriggerEl);
      });
    </script>
</body>

</html>